Quality of Life in Patients With Multiple Myeloma - NCT00290095-Oslo - 000 (Clinical Trial 137579)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy137579.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Oslo |
|
Country:
|
|
Norway |
|
|
|
| Conditions: |
|
Multiple Myeloma - Quality of Life |
| Purpose: |
|
The purpose of this study is to determine Clinically important difference and Response shift
in quality of life in patients with Multiple Myeloma.
|
| Study summary: |
|
Multiple myeloma is a plasma cell tumor with an annual incidence of 6 pr. 100 000. In the
absence of curative treatment, the aim of the therapy is not only to induce an objective
response and a prolongation of survival but also to improve the patients quality of life.
This project will raise two problems which make QoL-data hard to interpret
1. In a clinical trial where many patients are included, statistically significant
differences are obtained. However, there is widespread agreement that p-values do not
indicate whether a particular finding has clinical significance because statistical
significance does not necessarily equate to a meaningful difference or change in QoL. A
crucial task for clinicans in interpreting trial-based QoL results is to determine if
the observed change is clinically important to the patient.
2. When measuring changes in QoL in a pretest-posttest design,response shift can affect
results. Patients with advanced disease can report surprisingly good QoL.Including
response shift into quality of life research would allow a better understanding of
changes in the QoL that patients report. |
| Criteria: |
|
Inclusion Criteria:
- Multiple Myeloma
- Age > 18 years
- Informed consent
Exclusion Criteria:
- Terminal illness with life expectancy less than 3 months
- Unable to fill in a questionnaire in norwegian |
|
|
|
| Study is available at: |
|
Ullevaal University Hospital
Oslo
Norway
Primary Contact:
Ann Kristin Kvam, MD
Email: annkristin.kvam@ulleval.no
Phone: +47 41 92 72 52
Secondary Contact:
Ann Kristin Kvam, MD
Email: annkristin.kvam@ulleval.no
Phone: +47 41 92 72 52 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 3, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|